As of January 22, 2025, Prestige Consumer Healthcare (PBH) has a market cap of $3.82 billion USD. According to our data, Prestige Consumer Healthcare is ranked No.3092 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $3.82 B |
-0.90%
|
Dec 31, 2024 | $3.86 B |
27.56%
|
Dec 29, 2023 | $3.02 B |
-2.20%
|
Dec 30, 2022 | $3.09 B |
3.22%
|
Dec 31, 2021 | $3.00 B |
73.93%
|
Dec 31, 2020 | $1.72 B |
-13.90%
|
Dec 31, 2019 | $2.00 B |
31.15%
|
Dec 31, 2018 | $1.53 B |
-30.47%
|
Dec 29, 2017 | $2.19 B |
-14.76%
|
Dec 30, 2016 | $2.57 B |
1.20%
|
Dec 31, 2015 | $2.54 B |
48.27%
|
Dec 31, 2014 | $1.72 B |
-3.02%
|
Dec 31, 2013 | $1.77 B |
78.73%
|
Dec 31, 2012 | $0.99 B |
77.73%
|
Dec 30, 2011 | $0.56 B |
-5.69%
|
Dec 31, 2010 | $0.59 B |
52.04%
|
Dec 31, 2009 | $0.39 B |
-25.50%
|
Dec 31, 2008 | $0.52 B |
41.04%
|
Dec 31, 2007 | $0.37 B |
-42.55%
|
Dec 29, 2006 | $0.64 B |
4.16%
|
Dec 30, 2005 | $0.62 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Church & Dwight
CHD
|
$26.14 B |
0.001 M
|
USA
|
Procter & Gamble
PG
|
$387.95 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Colgate-Palmolive
CL
|
$71.52 B |
-8.176 M
|
USA
|
Unilever
UL
|
$138.62 B |
0.007 M
|
UK
|
Kimberly-Clark
KMB
|
$42.06 B |
0.001 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Perrigo
PRGO
|
$3.28 B |
0.000 M
|
Ireland
|
Haleon
HLN
|
$41.69 B |
-0.001 M
|
UK
|
Market Cap | = | PBH Stock Price | * | PBH Shares Outstanding |
= | $77.39 | * | 49.41 M | |
= | $3.82 B |